How to Access

This ESMO Webinar Series is available to all ESMO Members.

You will need to log in with your ESMO membership and click on the registration button. Access to the webinar will be open 30 min before the session starts.

Become an ESMO Member

Apply for an ESMO membership to register for this ESMO Webinar and enjoy all the benefits exclusive for members.

Live viewers of the webinar will be awarded a certificate of attendance and 2 ESMO-MORA category 1 points

Programme

4 September 2024

5 min

Welcome and introduction

Peter Schmid

15 min

Brain metastases: Prevention, screening and management

Nancy Lin

15 min

Optimal treatment sequences after guideline-based early breast cancer therapy

Volkmar Müller

15 min

Do we need to think about other targets as well?

Giuseppe Curigliano

15 min

What’s the role of the molecular tumour board-emerging concepts

Barbara Pistilli

15 min

QnA and Discussion

All speakers

Chairs’ welcome

It is with great pleasure that I invite you to participate in the ESMO Deep Dive Breast Cancer Webinar on the topic of HER2 positive metastatic breast cancer.

This webinar is developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.

We will begin with a brief welcome and introduction, then four lectures will be delivered on: brain metastases, optimal treatment sequences after guideline-based early breast cancer therapy and other potential targets, as well as the role of the molecular tumour board – emerging concepts. The lectures will be followed by a live discussion with the speakers’ panel.

This programme is designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with breast cancers, offer expert opinion exchange and provide some important considerations in this field. I strongly encourage and invite you to register and join us all in this new ESMO activity.

Prof. Peter Schmid

Peter Schmid
Chair

Barts Cancer Institute
London
Nancy U. Lin
Speaker

Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA
Volkmar Müller
Speaker

Department of Gynecology and University Breast Center, University Medical Center Hamburg-Eppendorf (UKE)
Giuseppe Curigliano
Speaker

University of Milan and European Institute of Oncology, IRCCS
Milan
Barbara Pistilli
Speaker

Gustave Roussy, Villejuif

Learning objectives

To acquire a deeper understanding of the clinical course of malignant disease of breast cancer.
To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for breast cancer.
To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.
To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.

Programme

Chairs’ welcome

Learning objectives

Supported by

Meeting resources

You may also be interested in...

Related Links